FDA 483 - UNC Healthcare/Fertility - July 20, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of UNC Healthcare/Fertility in Raleigh, NC, identified a significant deficiency related to donor eligibility procedures for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P). The firm failed to establish and maintain adequate procedures for screening and determining HCT/P donor eligibility, specifically lacking comprehensive steps, questionnaire guidance, and clarity on who can determine eligibility. This indicates a moderate severity issue concerning HCT/P donor screening practices.
- Office
- Atlanta District Office
- Person
ID · 745ee5f2-a7cb-475a-a3bb-c41f7fad3494